![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web |
Breast Cancer |
Free Subscription
1 Ann Oncol |
Retrieve available abstracts of this week’s articles:
HTML format Text format |
Single Articles |
AMEDEO Breast Cancer is free of charge.
Genomic alterations in breast cancer: Level of evidence for actionability
according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).
Ann Oncol. 2019 Jan 31. pii: 5305018. doi: 10.1093.
PubMed
Text format
Abstract available
ASO Author Reflections: Oncotype DX RS Complementing the Prognostic Stage in the
Updated AJCC 8th Edition for T1-2N1M0 ER-Positive HER2-Negative Breast Cancer.
Ann Surg Oncol. 2019 Jan 31. pii: 10.1245/s10434-019-07198.
PubMed
Text format
Reproductive Health Issues for Young Women with Breast Cancer: Emerging
Strategies for Difficult Situations.
Ann Surg Oncol. 2019 Feb 1. pii: 10.1245/s10434-019-07205.
PubMed
Text format
Effect of High-dose Vitamin C Combined With Anti-cancer Treatment on Breast
Cancer Cells.
Anticancer Res. 2019;39:751-758.
PubMed
Text format
Abstract available
Autoimmunity and Benefit from Trastuzumab Treatment in Breast Cancer: Results
from the HERA Trial.
Anticancer Res. 2019;39:797-802.
PubMed
Text format
Abstract available
A Potent CD1d-binding Glycolipid for iNKT-Cell-based Therapy Against Human Breast
Cancer.
Anticancer Res. 2019;39:549-555.
PubMed
Text format
Abstract available
Prevalence of germline mutations in the TP53 gene in patients with early-onset
breast cancer in the Mexican population.
BMC Cancer. 2019;19:118.
PubMed
Text format
Abstract available
Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor
front and tumor center are associated with response to neoadjuvant chemotherapy
in primary breast cancer.
BMC Cancer. 2019;19:120.
PubMed
Text format
Abstract available
Efficacy and safety of RGB-02, a pegfilgrastim biosimilar to prevent
chemotherapy-induced neutropenia: results of a randomized, double-blind phase III
clinical study vs. reference pegfilgrastim in patients with breast cancer
receiving chemotherapy.
BMC Cancer. 2019;19:122.
PubMed
Text format
Abstract available
Risk prediction for breast Cancer in Han Chinese women based on a cause-specific
Hazard model.
BMC Cancer. 2019;19:128.
PubMed
Text format
Abstract available
Oestrogen receptor status and survival in women with BRCA2-associated breast
cancer.
Br J Cancer. 2019 Feb 6. pii: 10.1038/s41416-019-0376.
PubMed
Text format
Abstract available
Pharmacogenomic-pharmacokinetic study of selective estrogen-receptor modulators
with intra-patient dose escalation in breast cancer.
Breast Cancer. 2019 Feb 7. pii: 10.1007/s12282-019-00952.
PubMed
Text format
Abstract available
Clinical Predictive Factors for the Efficacy of Everolimus in Patients With
Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer: A Multicenter
Retrospective Cohort Study in Japan.
Breast Cancer (Auckl). 2019;13:1178223418825135.
PubMed
Text format
Abstract available
Parity Differently Affects the Breast Cancer Specific Survival from Ductal
Carcinoma In Situ to Invasive Cancer: A Registry-Based Retrospective Study from
Korea.
Breast Cancer (Auckl). 2019;13:1178223418825134.
PubMed
Text format
Abstract available
Breast Cancer (Dove Med Press)
Overview of the genetic basis toward early detection of breast cancer.
Breast Cancer (Dove Med Press). 2019;11:71-80.
PubMed
Text format
Abstract available
Radiologic complete response (rCR) in contrast-enhanced magnetic resonance
imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts
recurrence-free survival but not pathologic complete response (pCR).
Breast Cancer Res. 2019;21:19.
PubMed
Text format
Abstract available
A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer
patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling.
Breast Cancer Res. 2019;21:18.
PubMed
Text format
Abstract available
MiR-1287-5p inhibits triple negative breast cancer growth by interaction with
phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.
Breast Cancer Res. 2019;21:20.
PubMed
Text format
Abstract available
Exosomal miRNA profile as complementary tool in the diagnostic and prediction of
treatment response in localized breast cancer under neoadjuvant chemotherapy.
Breast Cancer Res. 2019;21:21.
PubMed
Text format
Abstract available
HER2 positive breast cancer patients having HER2 loss after neoadjuvant
chemotherapy should still be treated with adjuvant anti-HER2 treatment.
Breast Cancer Res Treat. 2019 Feb 1. pii: 10.1007/s10549-019-05151.
PubMed
Text format
Efficacy of self-administered complex decongestive therapy on breast
cancer-related lymphedema: a single-blind randomized controlled trial.
Breast Cancer Res Treat. 2019 Feb 2. pii: 10.1007/s10549-019-05136.
PubMed
Text format
Abstract available
An eight-lncRNA signature predicts survival of breast cancer patients: a
comprehensive study based on weighted gene co-expression network analysis and
competing endogenous RNA network.
Breast Cancer Res Treat. 2019 Feb 4. pii: 10.1007/s10549-019-05147.
PubMed
Text format
Abstract available
Impact of the updated 2018 ASCO/CAP guidelines on HER2 FISH testing in invasive
breast cancer: a retrospective study of HER2 fish results of 2233 cases.
Breast Cancer Res Treat. 2019 Feb 2. pii: 10.1007/s10549-019-05148.
PubMed
Text format
Abstract available
Change in study randomization allocation needs to be included in statistical
analysis: comment on 'Randomized controlled trial of weight loss versus usual
care on telomere length in women with breast cancer: the lifestyle, exercise, and
nutrition (LEA
Breast Cancer Res Treat. 2019 Feb 5. pii: 10.1007/s10549-019-05155.
PubMed
Text format
Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast
cancer and reduced left ventricular ejection fraction.
Breast Cancer Res Treat. 2019 Feb 5. pii: 10.1007/s10549-019-05139.
PubMed
Text format
Abstract available
ID2 and GJB2 promote early-stage breast cancer progression by regulating cancer
stemness.
Breast Cancer Res Treat. 2019 Feb 6. pii: 10.1007/s10549-018-05126.
PubMed
Text format
Abstract available
High-risk breast cancer surveillance with MRI: 10-year experience from the German
consortium for hereditary breast and ovarian cancer.
Breast Cancer Res Treat. 2019 Feb 6. pii: 10.1007/s10549-019-05152.
PubMed
Text format
Abstract available
Immune microenvironment of triple-negative breast cancer in African-American and
Caucasian women.
Breast Cancer Res Treat. 2019 Feb 6. pii: 10.1007/s10549-019-05156.
PubMed
Text format
Abstract available
Safety of eribulin as third-line chemotherapy in HER2-negative, advanced breast
cancer pre-treated with taxanes and anthracycline: OnSITE study.
Breast J. 2019 Feb 8. doi: 10.1111/tbj.13199.
PubMed
Text format
Abstract available
Breast cancer subtypes affect the nodal response after neoadjuvant chemotherapy
in locally advanced breast cancer: Are we ready to endorse axillary conservation?
Breast J. 2019 Feb 7. doi: 10.1111/tbj.13206.
PubMed
Text format
Abstract available
Restaging the axilla after neo-adjuvant chemotherapy for breast cancer:
Predictive factors for residual metastatic lymph node disease with negative
imaging findings.
Breast J. 2019 Feb 3. doi: 10.1111/tbj.13192.
PubMed
Text format
Abstract available
A randomized study to improve care for young women with breast cancer at
community and academic medical oncology practices in the United States: The Young
and Strong study.
Cancer. 2019 Feb 1. doi: 10.1002/cncr.31984.
PubMed
Text format
Abstract available
Change in health-related quality of life in older women after diagnosis of a
small breast cancer.
Cancer. 2019 Feb 1. doi: 10.1002/cncr.31993.
PubMed
Text format
Abstract available
Primary care provider-reported involvement in breast cancer treatment decisions.
Cancer. 2019 Feb 1. doi: 10.1002/cncr.31998.
PubMed
Text format
Abstract available
Combined bazedoxifene and paclitaxel treatments inhibit cell viability, cell
migration, colony formation, and tumor growth and induce apoptosis in breast
cancer.
Cancer Lett. 2019 Jan 29. pii: S0304-3835(19)30046.
PubMed
Text format
Abstract available
Spleen tyrosine kinase-mediated autophagy is required for epithelial-mesenchymal
plasticity and metastasis in breast cancer.
Cancer Res. 2019 Feb 7. pii: 0008-5472.CAN-18-2636.
PubMed
Text format
Abstract available
MicroRNA-708 activation by glucocorticoid receptor agonists regulate breast
cancer tumorigenesis and metastasis via downregulation of NF-kappaB signaling.
Carcinogenesis. 2019 Feb 1. pii: 5307244. doi: 10.1093.
PubMed
Text format
Abstract available
Soy Foods Might Weaken the Sensitivity of Tamoxifen in Premenopausal Patients
With Lumina A Subtype of Breast Cancer.
Clin Breast Cancer. 2018 Dec 12. pii: S1526-8209(18)30645.
PubMed
Text format
Abstract available
Ligand binding domain activating mutations of ESR1 rewire cellular metabolism of
breast cancer cells.
Clin Cancer Res. 2019 Feb 7. pii: 1078-0432.CCR-18-1505.
PubMed
Text format
Abstract available
Genetic ancestry-dependent differences in breast cancer-induced field defects in
the tumor-adjacent normal breast.
Clin Cancer Res. 2019 Feb 4. pii: 1078-0432.CCR-18-3427.
PubMed
Text format
Abstract available
A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone
Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast
Cancer (NEO-ORB).
Clin Cancer Res. 2019 Feb 5. pii: 1078-0432.CCR-18-3160.
PubMed
Text format
Abstract available
Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced
breast cancer: Primary results from the KAMILLA study cohort 1.
Eur J Cancer. 2019;109:92-102.
PubMed
Text format
Abstract available
Are we close to the end of the primary tumor resection discussion for de novo
stage IV BC?
Eur J Surg Oncol. 2019;45:81-82.
PubMed
Text format
Does the subtype of breast cancer affect the diagnostic performance of axillary
ultrasound for nodal staging in breast cancer patients?
Eur J Surg Oncol. 2019 Jan 14. pii: S0748-7983(19)30035.
PubMed
Text format
Abstract available
An analysis of 11.3 million screening tests examining the association between
recall and cancer detection rates in the English NHS breast cancer screening
programme.
Eur Radiol. 2019 Feb 4. pii: 10.1007/s00330-018-5957.
PubMed
Text format
Abstract available
Benign Breast Disease Increases Breast Cancer Risk Independent of Underlying
Familial Risk Profile: Findings from a Prospective Family Study Cohort (ProF-SC).
Int J Cancer. 2019 Feb 6. doi: 10.1002/ijc.32112.
PubMed
Text format
Abstract available
beta1 Integrin is Essential for Fascin-Mediated Breast Cancer Stem Cell Function
and Disease Progression.
Int J Cancer. 2019 Feb 4. doi: 10.1002/ijc.32183.
PubMed
Text format
Abstract available
Transcriptome analysis of Luminal Breast Cancer Reveals a Role for LOL in Tumor
Progression and Tamoxifen Resistance.
Int J Cancer. 2019 Feb 5. doi: 10.1002/ijc.32185.
PubMed
Text format
Abstract available
Molecular Alterations and Poziotinib Efficacy, a pan-HER inhibitor, in Human
Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancers: Combined
Exploratory Biomarker Analysis from a Phase II Clinical Trial of Poziotinib for
Refractory HER2-po
Int J Cancer. 2019 Feb 5. doi: 10.1002/ijc.32188.
PubMed
Text format
Abstract available
Prevalence and clinical outcomes of germline mutations in BRCA1/2 and PALB2 genes
in 2769 unselected breast cancer patients in China.
Int J Cancer. 2019 Feb 5. doi: 10.1002/ijc.32184.
PubMed
Text format
Abstract available
Partial agonistic effect of cetuximab on epidermal growth factor receptor and Src
kinase activation in triplenegative breast cancer cell lines.
Int J Oncol. 2019 Jan 28. doi: 10.3892/ijo.2019.4697.
PubMed
Text format
Abstract available
RBM3 upregulates ARPC2 by binding the 3'UTR and contributes to breast cancer
progression.
Int J Oncol. 2019 Jan 28. doi: 10.3892/ijo.2019.4698.
PubMed
Text format
Abstract available
Local-therapy decisional regret in older women with breast cancer: A
population-based study.
Int J Radiat Oncol Biol Phys. 2019 Feb 1. pii: S0360-3016(19)30180.
PubMed
Text format
Abstract available
Image Guided Evolution of Nodal Contouring Guidelines in Breast Cancer.
Int J Radiat Oncol Biol Phys. 2019;103:592-594.
PubMed
Text format
TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic
Complete Response to Pertuzumab and Trastuzumab in Breast Cancer.
J Clin Oncol. 2019 Feb 5:JCO2018787986. doi: 10.1200/JCO.2018.78.7986.
PubMed
Text format
Abstract available
Artificial Intelligence for Breast Cancer Imaging: The New Frontier?
J Natl Cancer Inst. 2019 Feb 5. pii: 5307046. doi: 10.1093.
PubMed
Text format
The Risk of Heart Failure and Other Cardiovascular Hospitalizations After Early
Stage Breast Cancer: A Matched Cohort Study.
J Natl Cancer Inst. 2019 Jan 31. pii: 5304781. doi: 10.1093.
PubMed
Text format
Abstract available
Cardiac Disease After Breast Cancer Treatment: Make Sure to Check Our Blind Spot!
J Natl Cancer Inst. 2019 Jan 31. pii: 5304780. doi: 10.1093.
PubMed
Text format
Relevance of measurement uncertainty for quantitative response assessment of
breast cancer bone metastases with (18)F-fluoride.
J Nucl Med. 2019 Feb 7. pii: jnumed.119.226092. doi: 10.2967/jnumed.119.226092.
PubMed
Text format
A cost-effectiveness analysis of DIEP vs free MS-TRAM flap for microsurgical
breast reconstruction.
J Surg Oncol. 2019;119:388-396.
PubMed
Text format
Abstract available
Disease-free survival as a surrogate for overall survival in patients with
HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1
year: a systematic review and meta-analysis.
Lancet Oncol. 2019 Jan 29. pii: S1470-2045(18)30750.
PubMed
Text format
Abstract available
Endpoint selection in HER2-positive early breast cancer.
Lancet Oncol. 2019 Jan 29. pii: S1470-2045(18)30779.
PubMed
Text format
Hypofractionated versus conventional fractionated postmastectomy radiotherapy for
patients with high-risk breast cancer: a randomised, non-inferiority, open-label,
phase 3 trial.
Lancet Oncol. 2019 Jan 30. pii: S1470-2045(18)30813.
PubMed
Text format
Abstract available
pAKT pathway activation is associated with PIK3CA mutations and good prognosis in
luminal breast cancer in contrast to p-mTOR pathway activation.
NPJ Breast Cancer. 2019;5:7.
PubMed
Text format
Abstract available
Correction: Musashi RNA-binding protein 2 regulates estrogen receptor 1 function
in breast cancer.
Oncogene. 2019 Feb 4. pii: 10.1038/s41388-019-0721.
PubMed
Text format
Abstract available
WNT signaling modulates PD-L1 expression in the stem cell compartment of
triple-negative breast cancer.
Oncogene. 2019 Jan 31. pii: 10.1038/s41388-019-0700.
PubMed
Text format
Abstract available
Cellular and radiobiological effects of carbonic anhydrase IX in human breast
cancer cells.
Oncol Rep. 2019 Feb 5. doi: 10.3892/or.2019.7001.
PubMed
Text format
Abstract available
Current Strategies for the Management of Locoregional Breast Cancer Recurrence.
Oncology (Williston Park). 2019;33.
PubMed
Text format
Abstract available
The combined survival effect of codon 72 polymorphisms and p53 somatic mutations
in breast cancer depends on race and molecular subtype.
PLoS One. 2019;14:e0211734.
PubMed
Text format
Abstract available
Infiltration of CD8(+) T cells into tumor cell clusters in triple-negative breast
cancer.
Proc Natl Acad Sci U S A. 2019 Feb 7. pii: 1817652116.
PubMed
Text format
Abstract available
ERVmap analysis reveals genome-wide transcription of human endogenous
retroviruses.
Proc Natl Acad Sci U S A. 2018;115:12565-12572.
PubMed
Text format
Abstract available
AhR controls redox homeostasis and shapes the tumor microenvironment in
BRCA1-associated breast cancer.
Proc Natl Acad Sci U S A. 2019 Feb 7. pii: 1815126116.
PubMed
Text format
Abstract available
Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer.
Proc Natl Acad Sci U S A. 2019 Feb 7. pii: 1815034116.
PubMed
Text format
Abstract available
Imaging-guided Percutaneous Ablation: A Step Forward to Minimize the Invasiveness
of Breast Cancer Treatment.
Radiology. 2019 Feb 5:182448. doi: 10.1148/radiol.2019182448.
PubMed
Text format
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by